Breast Implant Recall

Allergan’s Biocell textured breast implants have been linked to a rare cancer called anaplastic large cell lymphoma (ALCL) and are now subject to a worldwide breast implant recall.

Contact Our Breast Implant Recall Lawyers Today

The nationwide law firm of Bernstein Liebhard LLP is offering free, no obligation legal reviews to any woman diagnosed with ALCL following augmentation or reconstructive surgery with Allergan’s Biocell textured breast implants. To contact our breast implant recall lawyers today, please call (888) 994-5118.

Allergan Biocell Breast Implants: What’s the Problem?

The U.S. Food & Drug Administration (FDA) began investigating a possible link between textured breast implants and ALCL, a rare form of non-Hodgkin’s lymphoma that develops in the tissue surrounding the devices, in 2011.

By July 2019, the agency had identified 573 confirmed cases of breast implant cancer, including 33 deaths. At least 481 cases involved Allergan’s textured Biocell implants. Although the FDA was only able to identify the manufacturer in 13 of the fatalities, 12 of those cases also involved the Allergan breast implants.

The FDA estimated that the risk of ALCL with Biocell textured breast implants is approximately six times higher compared to the risk associated with other textured devices marketed in the United States. As a result, the agency requested that the breast implants be recalled.

Allergan Breast Implant Recall

On July 24, 2019, Allergan announced a worldwide breast implant recall for Biocell textured implants and tissue expanders, including:

  • Natrelle Saline breast implant styles 168, 363, 468
  • Natrelle and McGhan 410 breast implant styles LL, LM, LF, LX, ML, MM, MF, MX, FL, FM, FF, FX
  • Natrelle and McGhan 410 Soft Touchbreast implant styles LL, LM, LF, LX, ML, MM, MF, MX, FL, FM, FF, FX
  • Natrelle 510 Dual-Gel styles LX, MX, FX
  • Natrelle INSPIRA breast implants, styles TRL, TRLP, TRM, TRF, TRX, TSL, TSLP, TSM, TSF, TSX, TCL, TCLP, TCM, TCF, TCX
  • Natrelle and McGhan Round Gel Implants, styles 110, 110 Soft Touch, 120, 120 Soft Touch
  • Natrelle Komuro breast implants styles KML, KMM, KLL, and KLM
  • Natrelle Ritz Princess breast implant styles RML, RMM, RFL, RFM
  • Natrelle 150 Full Height and Short Height double lumen implants
  • Natrelle 133 tissue expanders with and without suture tabs:  styles 133FV, 133MV, 133LV, 133MX, 133SX, 133SV, T-133FV, T-133MV, T-133LV, T-133MX, T-133SX, T-133SV, 133FV-T, 133MV-T, 133LV-T, 133MX-T, 133SX-T, 133SV-T
  • Natrelle 133 Plus tissue expander styles 133P-FV, 133P-MV, 133P-LV, 133P-MX, 133P-SX,
    133P-SV, T-133P-FV, T-133P-MV, T-133P-LV, T-133P-MX, T-133P-SX, T-133P-SV, 133P-FV-T, 133P-MV-T, 133P-LV-T, 133P-MX-T, 133P-SX-T, 133P-SV-T

The breast implant recall did not include Allergan’s Natrelle smooth or Microcell breast implants and tissue expanders.

What to Do If Your Breast Implants Were Recalled

The FDA is not recommending removal of Biocell textured breast implants for women without symptoms of ALCL. But because the disease can develop years after breast augmentation or reconstructive surgery, the agency is advising patients to monitor the area around their implants and report any changes to their doctor.

The signs and symptoms of breast implant cancer include:

  • Excessive fluid buildup around the breast implant
  • Pain
  • Swelling
  • Lumps in the breast or armpit

Breast implant-associated ALCL is very treatable if detected early. Treatment generally includes removal of the implant, as well as removal of the surrounding scar capsule.

Learn More About Filing a Breast Implant Lawsuit

You could be entitled to significant financial compensation if you or a loved one received any of the products’ included in the Allergan Biocell breast implant recall and were later diagnosed with ALCL. To learn if you’re eligible to file a breast implant lawsuit, please fill out our online form, or call our office directly at (888) 994-5118.

  1. FDA (March 2017) “Questions and Answers about Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)”
  2. FDA (July 2019) “FDA Safety Communication”
  3. Allergan (July 2019) “Allergan Voluntarily Recalls BIOCELL Textured Breast Implants and Tissue Expanders”
Last Modified: July 26, 2019

Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.


Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest

Skip to content